Skip to main content

Table 2 Potential large animal application with DUS-targeted gene delivery

From: Utilization of diagnostic ultrasound and intravenous lipid-encapsulated perfluorocarbons in non-invasive targeted cardiovascular therapeutics

Disease entity

DUS frequency/trigging

Specific gene

Specific application

Diabetes

1:4

DNA-planned

Beta cell regeneration

Limb ischemia

1:4

DNA-planned VGE

Angiogenesis

Tumor

 

DNA

Tumor suppression

Tumor

1:10

ShRNA

Anti-angiogenesis